FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

84746004: Pituitary hormone (substance)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
140496012 Pituitary hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
826654011 Pituitary hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4455851000005115 hypofysært hormon da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


49 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pituitary hormone Is a Hypothalamus- og hypofysehormon false Inferred relationship Some
Pituitary hormone Is a Hypofyse- eller binyrehormon false Inferred relationship Some
Pituitary hormone This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Pituitary hormone (disposition) true Inferred relationship Some
Pituitary hormone Is a Hormone true Inferred relationship Some
Pituitary hormone Is a Substance with molecular messenger mechanism of action (substance) false Inferred relationship Some
Pituitary hormone Is a Hormoner og deres metabolitter og forstadier false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Anterior pituitary hormone Is a False Pituitary hormone Inferred relationship Some
Somatomedin Is a False Pituitary hormone Inferred relationship Some
Antidiuretic hormone Is a False Pituitary hormone Inferred relationship Some
Panhypopituitarism - anterior and posterior Interprets False Pituitary hormone Inferred relationship Some
X-linked panhypopituitarism (disorder) Interprets False Pituitary hormone Inferred relationship Some
Prepuberal panhypopituitarism Interprets False Pituitary hormone Inferred relationship Some
Panhypopituitarism Interprets False Pituitary hormone Inferred relationship Some
Pituitary dwarfism with small sella turcica Interprets False Pituitary hormone Inferred relationship Some
Idiopathic panhypopituitarism Interprets False Pituitary hormone Inferred relationship Some
Post-birth injury panhypopituitarism Interprets False Pituitary hormone Inferred relationship Some
Post-infarction panhypopituitarism Interprets False Pituitary hormone Inferred relationship Some
anden specificeret panhypopituitarisme Interprets False Pituitary hormone Inferred relationship Some
panhyperpituitarisme, ikke nærmere specificeret Interprets False Pituitary hormone Inferred relationship Some
Hormone radioassay - pituitary Component True Pituitary hormone Inferred relationship Some 1
kortikotropinpræparat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing melatonin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
humant væksthormon, rekombinant præparat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Hormone-induced hypopituitarism Causative agent False Pituitary hormone Inferred relationship Some
kortikotropiner The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Posterior pituitary hormones The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Pituitary (posterior lobe) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Somatrophic hormone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing anterior pituitary hormone (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Somatropin (substance) Is a False Pituitary hormone Inferred relationship Some
Product containing somatotropin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing pituitary hormone (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pituitary hormone Inferred relationship Some 1
Pituitary luteinizing hormone Is a False Pituitary hormone Inferred relationship Some
præparat baseret på hypofyseforlapsekstrakt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing corticotropin releasing factor (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Posterior pituitary hormone Is a True Pituitary hormone Inferred relationship Some
Macroprolactin (substance) Is a False Pituitary hormone Inferred relationship Some
Product containing follitropin alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing follitropin beta (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing sermorelin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
sermorelinacetat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
kortikotropinpræparat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing melatonin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
kortikotropiner The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
rekombinant humant follikelstimulerende hormon alfa 75 IE pulver og solvens til injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
rekombinant humant follikelstimulerende hormon alfa 150 IE pulver og solvens til injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
rekombinant humant follikelstimulerende hormon beta 600 IE/0,72 ml cylinderampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
rekombinant humant follikelstimulerende hormon beta 300 IE/0,36 ml cylinderampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
rekombinant humant follikelstimulerende hormon alfa 37,5 IE pulver og solvens til injektionsvæske, opløsning, ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
rekombinant humant follikelstimulerende hormon beta 100 IE/ml injektionsvæske, opløsning, hætteglas a 0,5ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
rekombinant humant follikelstimulerende hormon beta 200 IE/ml injektionsvæske, opløsning, hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
rekombinant humant follikelstimulerende hormon beta 300 IE/ml injektionsvæske, opløsning, hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
rekombinant humant follikelstimulerende hormon beta 400 IE/ml injektionsvæske, opløsning, hætteglas a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing tetracosactide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
cosyntropin 250 µg/1 ml injektionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
cosyntropin 1 mg/1 ml injektionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 1,8 IE (0,6 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 1,2 IE (0,4 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 0,6 IE (0,2 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rmc) 24 IE (8 mg), pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 16 IE (5,33 mg), pulver til injektionsvæske, rekonstitution + solvens + injektionssæt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 12 IE (4 mg) pulver og solvens til injektionsvæske, opløsning, fyldt sprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 2,4 IE (0,8 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 3 IE (1 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 16 IE (5,33 mg), pulver til injektionsvæske, opløsning, cylinderampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 16 IE (5,33 mg), pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rmc) 10 IE (3,33 mg), pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rmc) 4 IE (1,33 mg), pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 4 IE (1,33 mg), pulver og solvens til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Somatropin 12 mg powder for solution for injection cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 18 IE (6 mg), pulver og solvens til injektionsvæske, opløsning, cylinderampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 36 IE (12 mg), pulver og solvens til injektionsvæske, opløsning, cylinderampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 72 IE (24 mg), pulver og solvens til injektionsvæske, opløsning, cylinderampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
sermorelin 50 µg pulver og solvens til injektionsvæske, opløsning, ampuller The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 3,6 IE (1,2 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 4,2 IE (1,4 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 4,8 IE (1,6 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 5,4 IE (1,8 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 6 IE (2 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (epr) 3,33 mg/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (epr) 6,66 mg/ml injektionsvæske, opløsning, cylinderampul à 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (epr) 10 mg/ml injektionsvæske, opløsning, cylinderampul à 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin 4 mg pulver til injektionsvæske, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin 8,8 mg pulver til injektionsvæske, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin 13,5 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin 18 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin 22,5 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Somatrophic hormone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
somatropin (rbe) 5 mg (15 IE)/ml, injektionsvæske, opløsning, cylinderampul a 2 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
follitropin alfa 300 IE injektionsvæske, opløsning i fyldt pen a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
follitropin alfa 450 IE injektionsvæske, opløsning i fyldt pen a 0,75 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
follitropin alfa 900 IE injektionsvæske, opløsning i fyldt pen a 1,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
cosyntropin 25 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing somatrem (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing pituitary gonadotropin (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
cosyntropinpræparat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
humant væksthormon, rekombinant præparat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Bovine growth hormone recombinant preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
sometribovepræparat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing human menopausal gonadotropin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing somatotropin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
kortikotropinzinkhydroxidpræparat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
præparat baseret på hypofyseforlapsekstrakt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing prolactin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
kortikotropin 80 enheder/ml i gelatine, injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
Product containing somatropin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some
follitropin beta 300 IE injektionsvæske, opløsning, cylinderampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Some

Page 1 of 2 End


This concept is not in any reference sets

Back to Start